CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 51 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Returned to the company · Stock Option (Right to Buy) | −36,707 | 113,293 | ||
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise · Stock Option (Right to Buy) | −78,918 | 34,375 | ||
| 2021-06-30 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Option exercise · Stock Option (Right to Buy) | −9,824 | 140,176 | ||
| 2021-06-30 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award | +3,391 | $1.95 | $7K | 91,115 |
| 2021-06-30 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award | +2,260 | $1.95 | $4K | 12,260 |
| 2021-06-30 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +5,000 | $1.95 | $10K | 45,375 |
| 2021-05-01 | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2021-04-23 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise | +5,000 | $1.50 | $8K | 40,375 |
| 2021-04-23 | Singh Shawn CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2021-04-23 | Curley Joanne Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2021-03-19 | Underdown Brian J. Director | Option exercise | +2,500 | $1.50 | $4K | 2,500 |
| 2021-03-19 | Underdown Brian J. Director | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2021-03-19 | SAXE JON S Director | Option exercise | +2,500 | $1.50 | $4K | 5,751 |
| 2021-03-19 | SAXE JON S Director | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 | ||
| 2021-02-01 | Ginski Mark J SENIOR VP, HEAD OF CMC | Grant or award · Stock Options (Right to Buy) | +200,000 | 200,000 | ||
| 2020-12-31 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +5,000 | $0.45 | $2K | 35,375 |
| 2020-12-31 | DOTSON JERROLD DUANE VP, CFO AND SECRETARY | Grant or award | +5,000 | $0.45 | $2K | 10,000 |
| 2020-12-31 | Smith Mark Alan CHIEF MEDICAL OFFICER | Grant or award | +5,000 | $0.45 | $2K | 10,000 |
| 2020-12-31 | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | Grant or award | +5,000 | $0.45 | $2K | 87,724 |
Page 6 of 17 · 323 trades